AME
53
6
QCOM
55
-2
COP
42
2
HAL
50
4
AMGN
44
11
IPG
45
-7
MPC
65
3
LLY
60
-8
NWSA
84
2
SLG
50
-7
PM
45
-5
MDLZ
59
9
WAT
33
3
NOV
43
4
FSLR
50
6
APH
71
6
GE
71
-6
GWW
37
-2
OMC
47
-7
ORCL
63
4
AME
53
6
QCOM
55
-2
COP
42
2
HAL
50
4
AMGN
44
11
IPG
45
-7
MPC
65
3
LLY
60
-8
NWSA
84
2
SLG
50
-7
PM
45
-5
MDLZ
59
9
WAT
33
3
NOV
43
4
FSLR
50
6
APH
71
6
GE
71
-6
GWW
37
-2
OMC
47
-7
ORCL
63
4
Financhill
Back

INmune Bio 10K Form

Sell
5

INMB
INmune Bio

Last Price:
$2.25
Seasonality Move:
-2.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INMB News And Ratings

See the #1 stock for the next 7 days that we like better than INMB

INMB Financial Statistics

Sales & Book Value

Annual Sales: $14K
Cash Flow: $-6.8M
Price / Cash Flow: 0
Annual Sales: $1.29
Price / Book: 1.75

Profitability

EPS (TTM): -1.93000
Net Income (TTM): $-40.8M
Gross Margin: --
Return on Equity: -122.48%
Return on Assets: -88.91%

INmune Bio Earnings Forecast

Key INmune Bio Financial Ratios

  • The Research & Development expenses have been 236,900.00% of Revenue.
  • The Net Earning history of INMB is -300,585.71% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 2 years.

INmune Bio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: INMB
CUSIP: 45782T
Website: inmunebio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.64
Quick Ratio: 2.62

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INMB Technical Analysis vs Fundamental Analysis

Sell
5
INmune Bio (INMB) is a Sell

Is INmune Bio a Buy or a Sell?

  • INmune Bio stock is rated a Sell
    The current INmune Bio [INMB] share price is $2.24. The Score for INMB is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.